244 related articles for article (PubMed ID: 24056132)
1. Does D2 plus para-aortic nodal dissection surgery offer a better survival outcome compared to D2 surgery only for gastric cancer consistently? A definite result based on a hospital population of nearly two decades.
Zhang Y; Tian S
Scand J Surg; 2013; 102(4):251-7. PubMed ID: 24056132
[TBL] [Abstract][Full Text] [Related]
2. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
Sasako M; Sano T; Yamamoto S; Kurokawa Y; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K;
N Engl J Med; 2008 Jul; 359(5):453-62. PubMed ID: 18669424
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage].
Liang YX; Liang H; Ding XW; Wang XN; Zhang L; Wu LL; Liu HG; Jiao XG
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1071-6. PubMed ID: 24499714
[TBL] [Abstract][Full Text] [Related]
4. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
5. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
7. Tumor site and perigastric nodal status are the most important predictors of para-aortic nodal involvement in advanced gastric cancer.
de Manzoni G; Di Leo A; Roviello F; Marrelli D; Giacopuzzi S; Minicozzi AM; Verlato G
Ann Surg Oncol; 2011 Aug; 18(8):2273-80. PubMed ID: 21286941
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of para-aortic nodal dissection for advanced gastric cancer.
Morita S; Fukagawa T; Fujiwara H; Katai H
Eur J Surg Oncol; 2016 Sep; 42(9):1448-54. PubMed ID: 26876636
[TBL] [Abstract][Full Text] [Related]
9. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
10. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
11. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
Montenegro P; Flores L; Quintana S; Casanova L; Ruíz E; León J; Mantilla R
Rev Gastroenterol Peru; 2013; 33(1):34-8. PubMed ID: 23539054
[TBL] [Abstract][Full Text] [Related]
13. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
14. Extended lymph-node dissection for gastric cancer.
Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
[TBL] [Abstract][Full Text] [Related]
15. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
[TBL] [Abstract][Full Text] [Related]
17. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
[TBL] [Abstract][Full Text] [Related]
18. Stage migration caused by D2 dissection with para-aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial.
Yoshikawa T; Sasako M; Sano T; Nashimoto A; Kurita A; Tsujinaka T; Tanigawa N; Yamamoto S
Br J Surg; 2006 Dec; 93(12):1526-9. PubMed ID: 17051601
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]